San Diego, CA -- (SBWIRE) -- 05/20/2021 -- An investigation on behalf of investors in shares of Armata Pharmaceuticals Inc. (NYSE:ARMP) was announced over potential breaches of fiduciary duties by certain officers and directors at Armata Pharmaceuticals Inc. .
